Cutaneous interferon production in patients with Hodgkin's disease and other cancers infected with varicella or vaccinia.
D000328:Adult; D000368:Aged; D002644:Chickenpox / Q000188:drug therapy / Q000276:immunology*; D003168:Complement Fixation Tests; D003597:Cytosine Nucleotides / Q000627:therapeutic use; D005122:Exudates and Transudates / Q000276:immunology; D005260:Female; D005455:Fluorescent Antibody Technique; D006562:Herpes Zoster / Q000150:complications / Q000276:immunology*; D014645:Herpesvirus 3, Human / Q000276:immunology; D006689:Hodgkin Disease / Q000150:complications / Q000276:immunology*; D006801:Humans; D007223:Infant; D007372:Interferons / Q000032:analysis / Q000096:biosynthesis*; D007938:Leukemia / Q000150:complications; D007958:Leukocyte Count; D007962:Leukocytes / Q000276:immunology; D007970:Leukopenia / Q000150:complications; D008228:Lymphoma, Non-Hodgkin / Q000150:complications; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology*; D009711:Nucleotides / Q000627:therapeutic use; D012867:Skin / Q000276:immunology*; D012899:Smallpox / Q000150:complications / Q000209:etiology; D012900:Smallpox Vaccine / Q000009:adverse effects; D014611:Vaccination / Q000009:adverse effects; D014615:Vaccinia / Q000209:etiology / Q000276:immunology
D003597:Cytosine Nucleotides; D009711:Nucleotides; D012900:Smallpox Vaccine; D007372:Interferons